Injective Price Forecast: Nearing a breakout towards $55

Injective price edges closer to a breakout as it trades around $43.
The short-term target for INJ bulls would be $51, but $55 could be reached soon.
A twelve-hour candlestick close below $34.15 would invalidate the bullish thesis.

Injective (INJ) price has been consolidating for more than two months and is now showing signs of breakout. Patience could see investors realize double-digit gains in the coming days.

Also read: Injective price could retest $50 as INJ bulls try to overcome critical resistance level

Injective price ready to move higher

After more than two months of consolidation, the Injective price is close to breaching the $31.09 to $43.40 range. INJ has produced three distinctive lower highs inside this range. Joining these swing points using a trend line shows that the altcoin faced a lot of selling pressure.

But the recent spike from buyers has pushed the Injective price to breach this declining resistance trend line level on February 27, resulting in a 13% rally. Interestingly, the liquidation event on March 5 knocked INJ down to retest this declining resistance level, confirming a successful flip into a support floor.

Now, Injective price is hovering just below the range high of $43.40, attempting to overcome it. As Bitcoin slips into consolidation, altcoins are likely to break out. In such a case, INJ could trigger a breakout, which could result in a quick 17% rally to $51. Considering the said target is close to the $50 whole number, INJ would naturally gravitate towards this level, making this a high probability level for bulls.

If the buying pressure continues to pour in, the Injective price could shoot up to $55, representing a 28% gain.

INJ/USDT 12-hour chart

On the other hand, if Injective price produces a twelve-hour candlestick close below $34.15, it would produce a lower low and invalidate the bullish thesis. Such a development could see INJ revisit the range low at $31.09, or a decline of 9%.

Share: Cryptos feed

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.